CYVNY — Opthea Ltd

—
OTC · Health Care · Biotechnology · CIK 1815620 · Australia
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
No quarterly fundamentals indexed for this ticker.

Balance + Analyst (yfinance extras)

Retained Earnings
$-711,622,000
Inventory
—
Receivables
$7,984,000
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,000
EBITDA
$-11,937,000
Free Cash Flow
$-16,207,750
Enterprise Value
$-24,036,096
Total Cash
$30,021,000
Total Debt
$0
Shares Out
170,997,272
Trailing EPS
$1.33
Book Value
$0.12
ROE
—
ROA
-12.6%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Jun 2026 1,000 -11,947,000 330,445,000 31,932,000 2,317,000 29,615,000 —
Jun 2025 39,000 -236,443,000 -251,146,000 86,700,000 393,613,000 -306,913,000 —
Jun 2024 187,014 -287,016,735 -329,506,259 282,452,103 395,872,202 -113,420,099 -161,015,354
Jun 2023 163,159 -226,647,268 -215,310,750 149,020,400 157,862,972 -8,842,572 -120,608,379
Jun 2022 — — — — — — -71,334,952

Peers — same industry

TickerNameMarket CapLastDaily %
AMGN AMGEN INC $247.70B $457.93 —
GILD GILEAD SCIENCES, INC. $211.18B $170.26 —
MRNA Moderna, Inc. $82.56B $206.80 —
ARGX ARGENX SE $58.92B $947.52 —
BIIB BIOGEN INC. $37.07B $250.79 —

Recent Insider Activity

No insider activity indexed for this ticker.